RHUMBLINE ADVISERS - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 86 filers reported holding CYTEK BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,777,379
-28.3%
321,992
+10.9%
0.00%
-33.3%
Q2 2023$2,480,203
+180541.2%
290,422
+94.4%
0.00%
+50.0%
Q1 2023$1,373
-5.7%
149,367
+4.8%
0.00%0.0%
Q4 2022$1,456
-99.9%
142,563
+1.3%
0.00%
-33.3%
Q3 2022$2,071,000
+49.6%
140,718
+9.1%
0.00%
+50.0%
Q2 2022$1,384,000
+33.3%
128,967
+34.0%
0.00%
+100.0%
Q1 2022$1,038,000
+328.9%
96,278
+549.5%
0.00%
Q4 2021$242,000
-4.0%
14,823
+26.0%
0.00%
Q3 2021$252,00011,7610.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,300,000$13,273,0008.92%
Miura Global Management 780,000$7,963,8004.01%
RA Capital Management 13,381,054$136,620,5612.77%
HHLR ADVISORS, LTD. 8,684,530$88,669,0511.87%
Brown Capital Management 5,107,878$52,151,4340.86%
Perceptive Advisors 1,289,534$13,166,1420.37%
Hillsdale Investment Management Inc. 344,529$3,517,6410.30%
PURA VIDA INVESTMENTS, LLC 420,749$4,295,8470.22%
FOX RUN MANAGEMENT, L.L.C. 19,881$202,9850.08%
INNOVIS ASSET MANAGEMENT LLC 14,565$148,7090.07%
View complete list of CYTEK BIOSCIENCES INC shareholders